Journal Information

Statistics

Follow this link to access the full text of the article

434
HEALTH-RELATED QUALITY OF LIFE OUTCOMES FROM THE PHASE 3 CANDOR STUDY COMPARING CARFILZOMIB, DEXAMETHASONE, AND DARATUMUMAB TO CARFILZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
D.S. Siegela, K. Weiselb, A. Zahlten-Kumelic, R. Medhekarc, S. Saprac, B. Dingc, X. Leleud
a John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, United States
b Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
c Amgen Inc., Thousand Oaks, United States
d Hôpital Claude Huriez, Lille, France
Read
1066
Times
was read the article
495
Total PDF
401
Total HTML
170
Total EPUB
Share statistics
Article information
ISSN: 25311379
Original language: English
The statistics are updated each day
Year/Month Html Pdf Epub Total
2022 June 12 20 8 40
2022 May 16 22 4 42
2022 April 11 32 9 52
2022 March 12 14 2 28
2022 February 13 24 4 41
2022 January 9 13 6 28
2021 December 11 22 6 39
2021 November 14 17 4 35
2021 October 16 36 7 59
2021 September 20 31 7 58
2021 August 25 33 10 68
2021 July 22 35 6 63
2021 June 17 22 3 42
2021 May 17 34 11 62
2021 April 88 50 30 168
2021 March 30 32 10 72
2021 February 25 24 8 57
2021 January 10 9 4 23
2020 December 17 13 4 34
2020 November 16 12 27 55
Show all

Follow this link to access the full text of the article

Idiomas
Hematology, Transfusion and Cell Therapy

Subscribe to our newsletter